Discover how SciY empowers scientists

FHS
May 31, 2024
2:47 pm

In this interview, NewsMedical talks to Santi Dominguez about the genesis of SCiY, and how the
consortium intends to empower scientists and researchers.

Pharmalittle: FDA rejects Merck cough medicine; Sanofi abandons an ADC for lung cancer

Good morning, everyone. Damian Garde here, filling in for Ed Silverman in a week customarily devoted to deciding just which tasks one can get away

December 21, 2023

Stanford and Intonation partner to develop new treatments for neuroendocrine tumors

Stanford University’s Innovative Medicines Accelerator (IMA) and Intonation Research Laboratories (Intonation) have formed a collaboration to develop treatments that target cancerous neuroendocrine tumors, or tumors

June 24, 2023

A Changing Treatment Landscape in Myasthenia Gravis

After years of a therapeutic drought in generalized myasthenia gravis (gMG), new targeted therapies are finally providing options for rapidly effective and safe treatment. This

November 4, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.